MoneyWorks4Me

Lupin - Quaterly Results

27 Oct 2021 Evaluate
The sales for the September 2021 quarter moved down to Rs. 28701.70 millions as compared to Rs. 30426.00 millions during the year-ago period.The Net Loss for the quarter ended September 2021 is Rs. -13291.20 millions as compared to Net Profit of Rs. 3604.30 millions of corresponding quarter ended September 2020Operating profit Margin for the quarter ended September 2021 slipped to -13242.70% as compared to 6230.70% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 28701.70 30426.00 -5.67 61842.90 57376.80 7.78 110559.30 110256.60 0.27
Other Income 746.80 252.90 195.29 1263.60 593.00 113.09 1290.90 4751.90 -72.83
PBIDT -13242.70 6230.70 -312.54 -3347.20 12523.80 -126.73 21731.50 23828.00 -8.80
Interest 182.60 91.30 100.00 330.80 178.10 85.74 406.20 525.90 -22.76
PBDT -13425.30 6139.40 -318.67 -3678.00 12345.70 -129.79 21325.30 15710.00 35.74
Depreciation 1299.00 1256.00 3.42 2552.60 2507.40 1.80 5028.30 5187.50 -3.07
PBT -14724.30 4883.40 -401.52 -6230.60 9838.30 -163.33 16297.00 10522.50 54.88
TAX -1433.10 1279.10 -212.04 601.90 2598.20 -76.83 3710.80 3247.00 14.28
Deferred Tax 1760.30 -20.30 -8771.43 1729.70 -73.80 -2443.77 82.30 -373.50 -122.03
PAT -13291.20 3604.30 -468.76 -6832.50 7240.10 -194.37 12586.20 7275.50 72.99
Equity 908.10 906.50 0.18 908.10 906.50 0.18 907.40 906.00 0.15
PBIDTM(%) -46.14 20.48 -325.31 -5.41 21.83 -124.80 19.66 21.61 -9.05
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..